FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNOFUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNOFUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪1.89 B‬TWD
Fund flows (1Y)
‪−540.10 M‬TWD
Dividend yield (indicated)
Discount/Premium to NAV
0.4%

About FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

Issuer
Fubon Financial Holding Co., Ltd.
Brand
Fubon
Expense ratio
1.05%
Inception date
Oct 4, 2021
Index tracked
NYSE FactSet Global Genomics and Immuno Biopharma Index
Management style
Passive
ISIN
TW0000089705
Fubon NYSE FactSet Global Genomics and Immuno Biopharma Exchange Traded Fund seeks investment results that closely track the performance of NYSE FactSet Global Genomics and Immuno Biopharma Index, before fees and expenses

Classification

Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
73%16%10%
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy